Protective Effects of Methanolic Extracts of *Calotropis gigantea* Leaves, Stem Bark and Roots against Diabetes-Induced Hepatic and Renal Dysfunction in Streptozotocin-Induced Albino Rats
Article Sidebar
Page Numbers:
293-315
Digital Object Identifier:
10.58578/ajbmbr.v3i3.11830
Viewed: 15 times
Downloaded: 0 times
LYAS Publisher cordially invites qualified professionals to serve as Editors or Reviewers. Your expertise will make an important contribution to maintaining and strengthening the academic quality of our publications. Interested applicants are kindly requested to complete the application form at the following link: Editors & Reviewers
Please feel free to contact us if you need any further information about the submission process or if you have any additional questions.
Authors:Mercy iliya Tumba1*, Isaac John Umaru2, Chinedu Imo3
Copyright :Authors retain copyright and grant the journal right of first publication.
Main Article Content
Abstract
Calotropis gigantea is widely used in traditional medicine, but comparative evidence concerning the antidiabetic and organ-protective effects of its different anatomical parts remains limited. This study evaluated the phytochemical constituents and therapeutic effects of methanolic extracts derived from the leaves, stem bark, and roots of C. gigantea in streptozotocin (STZ)-induced diabetic albino rats. Plant materials were air-dried, pulverized, extracted through cold maceration in methanol for 72 hours, and concentrated using a rotary evaporator. Phytochemical constituents were characterized by gas chromatography–mass spectrometry (GC–MS). Thirty-six male albino rats were randomly allocated to six groups: normal control, diabetic control, metformin-treated (100 mg/kg), and leaf-, stem-bark-, and root-extract-treated groups (100 mg/kg each). Treatments were administered for 14 days. Fasting blood glucose, liver and kidney function indices, and lipid profiles were assessed, alongside histopathological examination of liver and kidney tissues. GC–MS identified several bioactive constituents, including 7-octen-2-ol, α-terpineol, and D-limonene. Diabetes induction increased fasting blood glucose from 4.93 ± 0.25 to 16.14 ± 0.98 mmol/L, with concentrations remaining elevated in untreated diabetic rats. All extracts significantly reduced blood glucose, while the root extract produced the greatest reduction, from 15.37 ± 1.10 to 8.93 ± 1.94 mmol/L, comparable to the response observed with metformin. The root and leaf extracts produced the strongest improvements in renal function indices. The leaf extract yielded the most pronounced reductions in alanine aminotransferase, aspartate aminotransferase, and alkaline phosphatase activities and improved the lipid profile by reducing serum triglyceride and cholesterol concentrations while increasing high-density lipoprotein concentrations. Histopathological findings corroborated the biochemical results, demonstrating reduced hepatic and renal tissue damage in treated animals. These findings indicate that C. gigantea extracts, particularly those obtained from the roots and leaves, possess antidiabetic, hepatoprotective, nephroprotective, and lipid-modulating potential, supporting their further pharmacological evaluation for managing diabetes-associated complications.
Citation Metrics:
Downloads
Citation Metrics & Similar Scopus Articles
-
Liu Q. (2027)Elucidating the Respective Roles of Photochemical and Photothermal Effects in Photocatalytic Methanol DecompositionNano Micro Letters, 19(1)
-
Berenjian K. (2027)Impact of Mild Traumatic Brain Injury (mTBI) on CYP2D6 Activity and the Restorative Effects of Melatonin and Vitamin C SupplementationIranian Journal of Pharmaceutical Research, 26(1)
-
Sheng T. (2027)Photothermal Superhydrophobic Textiles: An Emerging Paradigm from Passive Water Repellency to Active Thermal ManagementNano Micro Letters, 19(1)
Article Details
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
References
Alicic, R. Z., Rooney, M. T., & Tuttle, K. R. (2017). Diabetic kidney disease: Challenges, progress, and possibilities. Clinical Journal of the American Society of Nephrology, 12(12), 2032–2045. https://doi.org/10.2215/CJN.11491116
American Diabetes Association. (2014). Diagnosis and classification of diabetes mellitus. Diabetes Care, 37(Suppl. 1), S81–S90. https://doi.org/10.2337/dc14-S081
Atanasov, A. G., Waltenberger, B., Pferschy-Wenzig, E. M., Linder, T., Wawrosch, C., Uhrin, P., Temml, V., Wang, L., Schwaiger, S., Heiss, E. H., Rollinger, J. M., Schuster, D., Breuss, J. M., Bochkov, V., Mihovilovic, M. D., Kopp, B., Bauer, R., Dirsch, V. M., & Stuppner, H. (2015). Discovery and resupply of pharmacologically active plant-derived natural products: A review. Biotechnology Advances, 33(8), 1582–1614. https://doi.org/10.1016/j.biotechadv.2015.08.001
Brownlee, M. (2005). The pathobiology of diabetic complications: A unifying mechanism. Diabetes, 54(6), 1615–1625. https://doi.org/10.2337/diabetes.54.6.1615
Chaudhury, A., Duvoor, C., Reddy Dendi, V. S., Kraleti, S., Chada, A., Ravilla, R., Marco, A., Shekhawat, N. S., Montales, M. T., Kuriakose, K., Sasapu, A., Beebe, A., Patil, N., Musham, C. K., Lohani, G. P., & Mirza, W. (2017). Clinical review of antidiabetic drugs: Implications for type 2 diabetes mellitus management. Frontiers in Endocrinology, 8, Article 6. https://doi.org/10.3389/fendo.2017.00006
Ekor, M. (2014). The growing use of herbal medicines: Issues relating to adverse reactions and challenges in monitoring safety. Frontiers in Pharmacology, 4, Article 177. https://doi.org/10.3389/fphar.2013.00177
Forouhi, N. G., & Wareham, N. J. (2014). Epidemiology of diabetes. Medicine, 42(12), 698–702. https://doi.org/10.1016/j.mpmed.2014.09.007
Giacco, F., & Brownlee, M. (2010). Oxidative stress and diabetic complications. Circulation Research, 107(9), 1058–1070. https://doi.org/10.1161/CIRCRESAHA.110.223545
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2015). Management of hyperglycemia in type 2 diabetes, 2015: A patient-centered approach. Diabetes Care, 38(1), 140–149. https://doi.org/10.2337/dc14-2441
Newman, D. J., & Cragg, G. M. (2016). Natural products as sources of new drugs from 1981 to 2014. Journal of Natural Products, 79(3), 629–661. https://doi.org/10.1021/acs.jnatprod.5b01055
Newsholme, P., Cruzat, V. F., Keane, K. N., Carlessi, R., & de Bittencourt, P. I. H. (2016). Molecular mechanisms of ROS production and oxidative stress in diabetes. Biochemical Journal, 473(24), 4527–4550. https://doi.org/10.1042/BJ20160503
Sies, H. (2017). Hydrogen peroxide as a central redox signaling molecule in physiological oxidative stress: Oxidative eustress. Redox Biology, 11, 613–619. https://doi.org/10.1016/j.redox.2016.12.035
Thomas, M. C., Brownlee, M., Susztak, K., Sharma, K., Jandeleit-Dahm, K. A. M., Zoungas, S., Rossing, P., Groop, P.-H., & Cooper, M. E. (2015). Diabetic kidney disease. Nature Reviews Disease Primers, 1, Article 15018. https://doi.org/10.1038/nrdp.2015.18
World Health Organization. (2016). Global report on diabetes. https://www.who.int/publications/i/item/9789241565257